Prevention and treatment of delayed ischaemic dysfunction in patients with subarachnoid haemorrhage : an update
著者
書誌事項
Prevention and treatment of delayed ischaemic dysfunction in patients with subarachnoid haemorrhage : an update
（Acta neurochirurgica, Supplementum,
Springer-Verlag, c1988
- (U.S.)
- (A.U.)
- タイトル別名
-
Delayed ischaemic dysfunction
大学図書館所蔵 全3件
注記
Spine title: Delayed ischaemic dysfunction
Includes bibliographical references
Based on papers presented at a symposium held during a meeting of the European Association of Neurosurgical Societies, Barcelona, September 1987
内容説明・目次
内容説明
During the last meeting of the European Association of Neurosurgical Societies (Barcelona 7-16 September 1987), a Symposium was devoted to the use of calcium antagonists in cerebral vasospasm. As shown by its title "Prevention and treatment of delayed ischaemic dysfunction in patients with subarachnoid haemorrhage: an update", papers presented at the Symposium covered a broad spectrum from some basic data on pathophysiology of subarachnoid haemorrhage (SAH) and delayed ischaemic dysfunction, to the clinical use of nimodipine, which has been largely documented among calcium inhibitors for its cerebrovascular properties. This supplementum of Acta Neurochirurgica is based upon the papers presented. Some articles, however, have been extended to take into account further results in order to present a broad view of the subject. The Symposium started with two presentations concerning general aspects of SAH: in the first one, B. Voldby reviewed the pathophysiological events following SAH: if modifications of intracranial pressure (ICP) and decrease of cerebral blood flow (CBF) are the primary alterations, metabolic changes (particularly reduction in CMR0 ) 2 contribute rapidly to disturbances of brain circulation. A variety of mechanisms may be responsible for the neurological dysfunction: most of them are directly related to the reduction in cerebral perfusion pressure (CPP) which may result in ischaemia. This fall in CPP (either due to elevation of ICP or reduction of mean arterial blood pressure) is observed under different pathophysiological conditions, discussed in the paper by A. D. Mendelow.
目次
Pathophysiology of Subarachnoid Haemorrhage. Experimental and Clinical Data.- Pathophysiology of Delayed Ischaemic Dysfunction After Subarachnoid Haemorrhage: Experimental and Clinical Data.- Cerebrovascular and Cerebral Effects of Nimodipine - an Update.- Haemodynamic Effectiveness of Nimodipine on Spastic Brain Vessels After Subarachnoid Haemorrhage Evaluated by the Transcranial Doppler Method. A Review of Clinical Studies.- Interactions Between Nimodipine and General Anaesthesia - Clinical Investigations in 124 Patients During Neurosurgical Operations.- Attempts at Prevention and Treatment of Delayed Ischaemic Dysfunction in Patients with Subarachnoid Haemorrhage.- Nimodipine in the Prevention of Ischaemic Deficits After Aneurysmal Subarachnoid Haemorrhage. An Analysis of Recent Clinical Studies.- Review of Treatment of Symptomatic Cerebral Vasospasm with Nimodipine.
「Nielsen BookData」 より